104 related articles for article (PubMed ID: 23027789)
1. Acquired long QT syndrome: frequency, onset, and risk factors in intensive care patients.
Kozik TM; Wung SF
Crit Care Nurse; 2012 Oct; 32(5):32-41. PubMed ID: 23027789
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and determinants of QT interval prolongation in medical inpatients.
Pasquier M; Pantet O; Hugli O; Pruvot E; Buclin T; Waeber G; Aujesky D
Intern Med J; 2012 Aug; 42(8):933-40. PubMed ID: 21299787
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of QT interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of QT interval-prolonging drugs: a prospective, observational study in a large urban academic medical center in the US.
Tisdale JE; Wroblewski HA; Overholser BR; Kingery JR; Trujillo TN; Kovacs RJ
Drug Saf; 2012 Jun; 35(6):459-70. PubMed ID: 22612851
[TBL] [Abstract][Full Text] [Related]
4. Frequency of high-risk use of QT-prolonging medications.
Allen LaPointe NM; Curtis LH; Chan KA; Kramer JM; Lafata JE; Gurwitz JH; Raebel MA; Platt R
Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):361-8. PubMed ID: 16178046
[TBL] [Abstract][Full Text] [Related]
5. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
[TBL] [Abstract][Full Text] [Related]
6. Pharmacist monitoring of QTc interval-prolonging medications in critically ill medical patients: a pilot study.
Ng TM; Bell AM; Hong C; Hara JM; Touchette DR; Danskey KN; Lindsay TT; Puumala SE
Ann Pharmacother; 2008 Apr; 42(4):475-82. PubMed ID: 18319393
[TBL] [Abstract][Full Text] [Related]
7. Cardiac arrest from acquired long QT syndrome: a case report.
Kozik TM; Wung SF
Heart Lung; 2009; 38(3):238-42. PubMed ID: 19486793
[TBL] [Abstract][Full Text] [Related]
8. T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: a new index for arrhythmogenicity.
Yamaguchi M; Shimizu M; Ino H; Terai H; Uchiyama K; Oe K; Mabuchi T; Konno T; Kaneda T; Mabuchi H
Clin Sci (Lond); 2003 Dec; 105(6):671-6. PubMed ID: 12857349
[TBL] [Abstract][Full Text] [Related]
9. The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias.
Topilski I; Rogowski O; Rosso R; Justo D; Copperman Y; Glikson M; Belhassen B; Hochenberg M; Viskin S
J Am Coll Cardiol; 2007 Jan; 49(3):320-8. PubMed ID: 17239713
[TBL] [Abstract][Full Text] [Related]
10. Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors.
Ehret GB; Voide C; Gex-Fabry M; Chabert J; Shah D; Broers B; Piguet V; Musset T; Gaspoz JM; Perrier A; Dayer P; Desmeules JA
Arch Intern Med; 2006 Jun; 166(12):1280-7. PubMed ID: 16801510
[TBL] [Abstract][Full Text] [Related]
11. Predicting torsade de pointes in acquired long QT syndrome: optimal identification of critical QT interval prolongation.
Chiladakis J; Kalogeropoulos A; Zagkli F; Koutsogiannis N; Chouchoulis K; Alexopoulos D
Cardiology; 2012; 122(1):3-11. PubMed ID: 22626988
[TBL] [Abstract][Full Text] [Related]
12. An algorithm for QT interval monitoring in neonatal intensive care units.
Helfenbein ED; Ackerman MJ; Rautaharju PM; Zhou SH; Gregg RE; Lindauer JM; Miller D; Wang JJ; Kresge SS; Babaeizadeh S; Feild DQ; Michaud FP
J Electrocardiol; 2007; 40(6 Suppl):S103-10. PubMed ID: 17993306
[TBL] [Abstract][Full Text] [Related]
13. Effect of arsenic trioxide on QT interval in patients with advanced malignancies.
Barbey JT; Pezzullo JC; Soignet SL
J Clin Oncol; 2003 Oct; 21(19):3609-15. PubMed ID: 14512391
[TBL] [Abstract][Full Text] [Related]
14. Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients: a cross-sectional study.
Peles E; Bodner G; Kreek MJ; Rados V; Adelson M
Addiction; 2007 Feb; 102(2):289-300. PubMed ID: 17222284
[TBL] [Abstract][Full Text] [Related]
15. Time course and prognostic implications of QT interval in patients with coronary artery disease undergoing coronary bypass surgery.
Kinoshita T; Asai T; Suzuki T; Matsubayashi K; Horie M
J Cardiovasc Electrophysiol; 2012 Jun; 23(6):645-9. PubMed ID: 22486896
[TBL] [Abstract][Full Text] [Related]
16. QT prolongation and Torsades de Pointes in patients previously treated with anthracyclines.
Arbel Y; Swartzon M; Justo D
Anticancer Drugs; 2007 Apr; 18(4):493-8. PubMed ID: 17351403
[TBL] [Abstract][Full Text] [Related]
17. Beat-to-beat variability of QT intervals is increased in patients with drug-induced long-QT syndrome: a case control pilot study.
Hinterseer M; Thomsen MB; Beckmann BM; Pfeufer A; Schimpf R; Wichmann HE; Steinbeck G; Vos MA; Kaab S
Eur Heart J; 2008 Jan; 29(2):185-90. PubMed ID: 18156612
[TBL] [Abstract][Full Text] [Related]
18. Magnitude of QT prolongation associated with a higher risk of Torsades de Pointes.
Lin YL; Kung MF
Pharmacoepidemiol Drug Saf; 2009 Mar; 18(3):235-9. PubMed ID: 19145580
[TBL] [Abstract][Full Text] [Related]
19. Torsades de pointes related to transient marked QT prolongation following successful emergent percutaneous coronary intervention for acute coronary syndrome.
Kawabata M; Hirao K; Takeshi S; Sakurai K; Inagaki H; Hachiya H; Isobe M
J Electrocardiol; 2008; 41(2):117-22. PubMed ID: 18328336
[TBL] [Abstract][Full Text] [Related]
20. Giant T-U waves precede torsades de pointes in long QT syndrome: a systematic electrocardiographic analysis in patients with acquired and congenital QT prolongation.
Kirchhof P; Franz MR; Bardai A; Wilde AM
J Am Coll Cardiol; 2009 Jul; 54(2):143-9. PubMed ID: 19573731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
